StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
633
This month
12
This week
2
This year
61
Today
1
Yesterday
1
Publishing Date
2024 - 04 - 16
3
2024 - 02 - 14
4
2024 - 01 - 30
3
2023 - 12 - 06
3
2023 - 11 - 28
3
2023 - 10 - 04
3
2023 - 09 - 11
3
2023 - 09 - 06
3
2023 - 08 - 30
3
2023 - 08 - 25
3
2023 - 05 - 19
3
2023 - 05 - 17
3
2023 - 05 - 03
3
2023 - 04 - 14
5
2023 - 04 - 13
5
2023 - 04 - 12
3
2023 - 03 - 28
4
2023 - 03 - 10
4
2023 - 02 - 27
4
2023 - 02 - 17
3
2023 - 02 - 08
3
2023 - 01 - 11
3
2023 - 01 - 04
4
2023 - 01 - 03
3
2022 - 12 - 16
3
2022 - 11 - 21
3
2022 - 10 - 06
4
2022 - 09 - 29
3
2022 - 09 - 28
3
2022 - 09 - 27
3
2022 - 09 - 26
3
2022 - 09 - 19
5
2022 - 09 - 15
4
2022 - 09 - 12
3
2022 - 09 - 08
5
2022 - 09 - 07
3
2022 - 09 - 05
3
2022 - 08 - 29
3
2022 - 08 - 25
3
2022 - 08 - 03
4
2022 - 07 - 27
3
2022 - 07 - 14
3
2022 - 06 - 29
3
2022 - 06 - 24
4
2022 - 06 - 09
3
2022 - 05 - 31
3
2022 - 05 - 17
3
2022 - 04 - 26
3
2022 - 04 - 04
4
2022 - 03 - 07
3
2022 - 02 - 28
3
2022 - 02 - 09
3
2022 - 01 - 19
3
2021 - 12 - 08
3
2021 - 10 - 27
3
2021 - 10 - 22
3
2021 - 10 - 21
3
2021 - 10 - 08
2
2021 - 10 - 01
2
2021 - 09 - 30
2
Sector
Communications
6
Consumer durables
1
Consumer non-durables
13
Electronic technology
2
Finance
6
Finance and insurance
1
Health services
1
Health technology
633
Manufacturing
65
Mining, quarrying, and oil and gas extraction
1
N/a
123
Process industries
14
Producer manufacturing
9
Professional, scientific, and technical services
3
Retail trade
2
Technology services
1
Tags
Active
10
Agreement
8
Ajovy
8
Alzheimer's
9
America
38
Application
11
Approval
13
Asia
13
Austedo
9
Avt02
11
Avt04
11
Biosimilar
42
Business
12
Cancer
21
Children
18
Clinical-trials-phase-iii
8
Collaboration
9
Conference
20
Dermatitis
8
Disease
36
Drug
44
Dupixent
34
Earnings
14
Europe
15
Events
10
Expected
12
Fda
22
Financial
21
Global
111
Growing
17
Growth
133
Health
11
Libtayo
8
License
11
Liver
8
Market
314
Migraine
9
N/a
516
Pharm-country
18
Pharma
12
Pharmaceuticals
9
Phase 3
15
Positive
14
Reach
16
Report
95
Research
59
Respiratory
10
Results
48
Review
8
Set
13
Stelara
12
Study
21
System
11
Teva
53
Therapeutics
64
Therapy
14
Treatment
76
Trial
12
Update
20
Year
8
Entities
3m company
938
Abb ltd
1433
Abbott laboratories
1797
Abbvie inc.
1030
Accenture plc
602
Alphabet inc.
1304
Amgen inc.
744
Apple inc.
1198
Arcelormittal
592
Arrival
4319
Astrazeneca plc
668
Bank of montreal
545
Becton, dickinson and company
796
Bnp paribas
1768
Boston scientific corporation
577
Bristol-myers squibb company
662
Broadcom inc.
597
Cisco systems, inc.
900
Cummins inc.
542
Danaher corporation
786
Dell technologies inc.
579
Dow inc.
556
Eli lilly and company
1711
Ericsson
1617
Extreme networks, inc.
581
First bank
602
Ford motor company
643
Gartner, inc.
595
General electric company
919
Glaxosmithkline plc
888
Honeywell international inc.
1792
Hubspot, inc.
1400
Intel corporation
955
International business machines corporation
657
Johnson & johnson
4606
Kering
1132
Koninklijke philips n.v.
963
Lithium corp
973
Live nation entertainment, inc.
717
Lockheed martin corporation
576
Medtronic plc
1286
Microsoft corporation
1205
Morgan stanley
4298
Nokia corp
993
Nokia corporation
917
Northrop grumman corporation
590
Novartis ag
1245
Novo nordisk a/s
636
Oracle corporation
1161
Orange
7229
Panasonic corp
651
Pfizer, inc.
693
Sanofi
4559
Sap se
1481
Snowflake inc.
796
Stellantis n.v
536
Teva pharmaceutical industries ltd
633
Thermo fisher scientific inc
1630
Verizon communications inc.
1223
X financial
678
Symbols
ABBV
130
ABT
43
ALB
8
ALC
4
ALKS
5
ALNY
4
ALPMF
27
ALPMY
27
ALVO
84
AMGN
83
ATR
5
ATRS
4
AVDL
4
AZN
85
AZNCF
85
BAX
25
BDX
4
BHC
33
BIIB
28
BMY
37
CMPI
4
CMXHF
6
CSLLY
6
DNLI
5
ENDP
28
ENDPQ
19
FNCTF
6
GILD
10
GLAXF
148
GSK
148
JAZZ
8
JNJ
81
KMDA
86
LLY
61
MDT
9
MMM
9
MNK
15
MNKKQ
13
MNKPF
10
MS
5
NTLA
6
NVO
15
NVS
206
NVSEF
206
PFE
29
PHG
12
PRGO
6
RBGLY
11
RBGPF
11
REGN
72
SNY
224
SNYNF
224
TAK
20
TARO
5
TEVA
64
TEVJF
633
TMO
8
UCBJF
7
UCBJY
7
VTRS
103
Exchanges
Nasdaq
633
Nyse
436
Crawled Date
2024 - 04 - 16
3
2024 - 02 - 14
4
2024 - 01 - 30
3
2024 - 01 - 19
3
2023 - 12 - 06
3
2023 - 11 - 28
3
2023 - 10 - 04
3
2023 - 09 - 11
3
2023 - 09 - 06
3
2023 - 08 - 30
3
2023 - 08 - 25
3
2023 - 05 - 17
3
2023 - 05 - 03
3
2023 - 04 - 14
5
2023 - 04 - 13
6
2023 - 03 - 28
4
2023 - 03 - 10
3
2023 - 02 - 27
4
2023 - 02 - 17
3
2023 - 01 - 04
4
2023 - 01 - 03
3
2022 - 12 - 16
3
2022 - 11 - 21
3
2022 - 10 - 06
4
2022 - 09 - 28
3
2022 - 09 - 27
3
2022 - 09 - 26
3
2022 - 09 - 19
5
2022 - 09 - 15
4
2022 - 09 - 12
3
2022 - 09 - 08
5
2022 - 09 - 07
3
2022 - 09 - 05
4
2022 - 08 - 29
3
2022 - 08 - 25
3
2022 - 08 - 03
4
2022 - 07 - 27
3
2022 - 07 - 14
3
2022 - 06 - 29
3
2022 - 06 - 24
4
2022 - 06 - 09
3
2022 - 05 - 31
3
2022 - 05 - 17
3
2022 - 04 - 26
3
2022 - 04 - 04
4
2022 - 03 - 07
3
2022 - 02 - 28
3
2022 - 02 - 09
3
2022 - 01 - 19
3
2021 - 12 - 08
3
2021 - 11 - 25
2
2021 - 11 - 12
2
2021 - 11 - 04
2
2021 - 10 - 27
3
2021 - 10 - 22
2
2021 - 10 - 21
3
2021 - 10 - 14
2
2021 - 10 - 08
2
2021 - 10 - 01
2
2021 - 09 - 30
2
Crawled Time
00:00
32
00:20
6
01:00
17
02:00
12
03:00
14
04:00
9
04:20
5
05:00
10
06:00
16
07:00
16
08:00
26
08:20
1
09:00
43
10:00
24
11:00
23
12:00
44
12:15
1
12:20
9
12:30
3
13:00
36
13:20
8
13:30
7
14:00
19
14:20
2
14:30
5
15:00
21
15:20
1
15:30
9
16:00
26
16:20
4
17:00
23
18:00
24
19:00
23
20:00
21
20:20
4
21:00
24
22:00
30
23:00
35
Source
ir.biolinerx.com
1
ir.vtvtherapeutics.com
1
www.biospace.com
117
www.globenewswire.com
96
www.prnewswire.com
418
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
entities :
Teva pharmaceutical industries ltd
save search
Global Glioblastoma Multiforme (GBM) Treatment Market Report 2023: Increasing Prevalence of Brain Disorders is Expected to Propel Growth
Published:
2023-05-17
(Crawled : 01:00)
- prnewswire.com
AZNCF
|
News
|
$140.3
-4.19%
1.5K
|
Health Technology
|
-7.21%
|
O:
-1.32%
H:
0.92%
C:
-1.34%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
-3.84%
|
O:
-0.51%
H:
0.0%
C:
-1.05%
FUSN
|
$21.4
-0.09%
-0.09%
270K
|
Health Technology
|
369.74%
|
O:
-1.54%
H:
1.34%
C:
-2.67%
DFFN
4
|
$6.6
11.68%
-34.32%
350K
|
Health Technology
|
14.59%
|
O:
-0.25%
H:
0.0%
C:
-0.78%
AZN
|
News
|
$71.175
0.46%
0.46%
6.1M
|
Health Technology
|
-5.88%
|
O:
0.07%
H:
0.03%
C:
-0.84%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
20.04%
|
O:
-0.82%
H:
0.03%
C:
-0.44%
propel
report
expected
treatment
global
growth
glioblastoma
market
Global Sleep Aids Market to 2031: Increasing Incidences of Sleep Disorders Drives Growth
Published:
2023-05-11
(Crawled : 01:00)
- prnewswire.com
RMD
|
$183.78
-0.24%
0.0%
970K
|
Health Technology
|
-21.1%
|
O:
-0.09%
H:
1.31%
C:
1.21%
GSK
|
News
|
$40.86
-0.92%
-0.15%
1.7M
|
Health Technology
|
12.89%
|
O:
-0.88%
H:
0.25%
C:
0.19%
SNBR
|
$13.58
-6.99%
-7.51%
670K
|
Consumer Durables
|
-30.81%
|
O:
-0.24%
H:
0.0%
C:
-2.42%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-13.01%
|
O:
-0.28%
H:
0.0%
C:
0.0%
global
growth
market
Diffuse Large B-Cell Lymphoma (DLBCL) Therapeutics Market Size to Grow by USD 1.79 billion, AbbVie Inc. and Bayer AG Among Key Vendors - Technavio
Published:
2022-07-25
(Crawled : 06:00)
- prnewswire.com
GLAXF
|
News
|
$19.54
-14.18%
2.6K
|
Health Technology
|
-9.12%
|
O:
0.0%
H:
0.0%
C:
0.0%
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
38.05%
|
O:
3.12%
H:
0.06%
C:
0.06%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
15.13%
|
O:
0.06%
H:
0.31%
C:
0.19%
GSK
|
News
|
$40.86
-0.92%
-0.15%
1.7M
|
Health Technology
|
-2.48%
|
O:
0.76%
H:
0.19%
C:
-1.06%
ADCT
|
$4.78
-3.82%
0.0%
280K
|
Health Technology
|
-32.47%
|
O:
0.14%
H:
0.0%
C:
-2.31%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
14.18%
|
O:
0.18%
H:
0.0%
C:
0.0%
CTIC
|
$9.09
0.05%
11M
|
Health Technology
|
41.89%
|
O:
-7.8%
H:
3.72%
C:
2.37%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
11.22%
|
O:
0.37%
H:
0.9%
C:
0.75%
therapeutics
market
Diffuse large B-cell lymphoma (DLBCL) therapeutics market size to increase by USD 2,061.88 million between 2022 and 2027; Growth driven by increasing approval of therapeutics - Technavio
Published:
2023-03-10
(Crawled : 23:00)
- prnewswire.com
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
Email alert
Add to watchlist
CTIC
|
$9.09
0.05%
11M
|
Health Technology
|
Email alert
Add to watchlist
GLAXF
|
News
|
$19.54
-14.18%
2.6K
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
Email alert
Add to watchlist
TEVJF
|
News
|
$12.37
-24.22%
380
|
Health Technology
|
Email alert
Add to watchlist
GSK
|
News
|
$40.86
-0.92%
-0.15%
1.7M
|
Health Technology
|
Email alert
Add to watchlist
ADCT
|
$4.78
-3.82%
0.0%
280K
|
Health Technology
|
Email alert
Add to watchlist
approval
therapeutics
growth
market
The Global Diffuse Large B-Cell Lymphoma (DLBCL) Therapeutics Market is forecast to grow by $ 2061.88 mn during 2022-2027, accelerating at a CAGR of 7.96% during the forecast period
Published:
2023-03-15
(Crawled : 15:20)
- prnewswire.com
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
41.18%
|
O:
2.62%
H:
0.0%
C:
-3.57%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
20.43%
|
O:
-1.0%
H:
1.39%
C:
1.02%
GSK
|
News
|
$40.86
-0.92%
-0.15%
1.7M
|
Health Technology
|
22.3%
|
O:
-0.95%
H:
1.05%
C:
0.54%
ADCT
|
$4.78
-3.82%
0.0%
280K
|
Health Technology
|
102.03%
|
O:
-0.81%
H:
3.48%
C:
-0.82%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
10.2%
|
O:
-1.09%
H:
1.45%
C:
1.24%
CTIC
|
$9.09
0.05%
11M
|
Health Technology
|
103.47%
|
O:
0.67%
H:
0.67%
C:
-2.22%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
18.63%
|
O:
-0.08%
H:
2.24%
C:
1.95%
global
therapeutics
market
Transdermal Drug Delivery - Global Market Trajectory Following COVID-19 Pandemic
Published:
2021-10-01
(Crawled : 17:00)
- prnewswire.com
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
20.89%
|
O:
-0.16%
H:
0.0%
C:
0.0%
DRRX
|
$0.9071
7.55%
7.02%
140K
|
Health Technology
|
-34.38%
|
O:
0.0%
H:
4.69%
C:
2.34%
ATRS
|
$5.59
0.0%
|
Health Technology
|
53.57%
|
O:
0.55%
H:
0.55%
C:
0.0%
covid
drug
drug delivery
liver
covid-19
Global Transdermal Drug Delivery Market to Reach $131.2 Billion by 2027
Published:
2023-01-21
(Crawled : 16:20)
- prnewswire.com
DRRX
|
$0.9071
7.55%
7.02%
140K
|
Health Technology
|
Email alert
Add to watchlist
TEVJF
|
News
|
$12.37
-24.22%
380
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
Email alert
Add to watchlist
ATRS
|
$5.59
0.0%
|
Health Technology
|
Email alert
Add to watchlist
drug
global
transdermal
market
Endo Unsecured Noteholders Group Reiterates that Bankruptcy is Unwarranted in Light of Recent Results
Published:
2022-08-10
(Crawled : 16:00)
- prnewswire.com
ENDP
|
News
|
$0.2926
-9.6%
|
Health Technology
|
-45.82%
|
O:
-22.24%
H:
4.76%
C:
3.0%
EGRX
|
$4.58
-3.98%
-4.15%
95K
|
Health Technology
|
-87.06%
|
O:
-0.03%
H:
2.1%
C:
-5.02%
results
group
Teva Reports Fourth Quarter and Full Year 2021 Financial Results
Published:
2022-02-09
(Crawled : 13:30)
- biospace.com/
EGRX
|
$4.58
-3.98%
-4.15%
95K
|
Health Technology
|
-89.37%
|
O:
3.87%
H:
1.76%
C:
0.69%
financial results
report
results
Oncternal Therapeutics Announces the Appointment of Jill DeSimone to the Board of Directors
Published:
2023-01-04
(Crawled : 22:00)
- biospace.com/
PRAX
|
$51.07
4.57%
4.37%
140K
|
Health Technology
|
1800.39%
|
O:
-2.33%
H:
7.97%
C:
3.98%
ONCT
|
$8.755
-0.11%
-0.11%
1.6K
|
Health Technology
|
759.8%
|
O:
2.94%
H:
0.95%
C:
-0.95%
therapeutics
Regeneron Reports First Quarter 2022 Financial and Operating Results
Published:
2022-05-04
(Crawled : 11:00)
- prnewswire.com
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-11.9%
|
O:
-3.68%
H:
0.0%
C:
0.0%
REGN
|
News
|
$906.55
-0.09%
-0.08%
370K
|
Health Technology
|
39.5%
|
O:
1.63%
H:
0.0%
C:
0.0%
NTLA
|
$21.16
-1.72%
-1.75%
860K
|
Health Technology
|
-58.23%
|
O:
-0.5%
H:
0.0%
C:
0.0%
CMPI
|
$10.5
0.0%
|
Health Technology
|
1.06%
|
O:
0.0%
H:
0.0%
C:
-0.19%
ACET
|
News
|
$1.87
-10.95%
-12.3%
1.4M
|
Health Technology
|
-86.27%
|
O:
0.46%
H:
0.0%
C:
0.0%
results
Global CNS Therapeutics Strategic Business Report 2023: Burgeoning Global Aging Populace, Longer Life Expectancy to Drive CNS Demand
Published:
2023-06-30
(Crawled : 23:00)
- prnewswire.com
ALKS
|
$24.66
1.65%
1.62%
1.7M
|
Health Technology
|
Email alert
Add to watchlist
JNJ
|
News
|
$148.53
-0.69%
-0.14%
9.6M
|
Health Technology
|
Email alert
Add to watchlist
NBIX
|
News
4
|
$138.91
-0.84%
-0.85%
880K
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
|
Email alert
Add to watchlist
UCBJY
|
$65.26
-4.38%
5.9K
|
Manufacturing
|
Email alert
Add to watchlist
UCBJF
|
$128.725
-39.66%
750
|
Health Technology
|
Email alert
Add to watchlist
AZNCF
|
News
|
$140.3
-4.19%
1.5K
|
Health Technology
|
Email alert
Add to watchlist
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
Email alert
Add to watchlist
TAK
|
News
|
$13.23
-1.12%
0.0%
920K
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
Email alert
Add to watchlist
BMY
|
$48.86
-0.27%
-0.02%
16M
|
Health Technology
|
Email alert
Add to watchlist
AZN
|
News
|
$71.175
0.46%
0.46%
6.1M
|
Health Technology
|
Email alert
Add to watchlist
TEVJF
|
News
|
$12.37
-24.22%
380
|
Health Technology
|
Email alert
Add to watchlist
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
Email alert
Add to watchlist
report
business
life
global
therapeutics
Global CNS Therapeutics Market Report 2022 - CNS Therapeutics Exhibit Robust Opportunities amidst Rising Incidence of CNS Disorders
Published:
2022-03-22
(Crawled : 14:00)
- prnewswire.com
GLAXF
|
News
|
$19.54
-14.18%
2.6K
|
Health Technology
|
-12.02%
|
O:
0.9%
H:
0.0%
C:
-8.17%
AZNCF
|
News
|
$140.3
-4.19%
1.5K
|
Health Technology
|
15.2%
|
O:
2.88%
H:
2.09%
C:
2.09%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
14.06%
|
O:
-0.93%
H:
0.0%
C:
0.0%
GSK
|
News
|
$40.86
-0.92%
-0.15%
1.7M
|
Health Technology
|
-4.34%
|
O:
0.79%
H:
0.0%
C:
0.0%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
5.93%
|
O:
0.0%
H:
0.16%
C:
-0.02%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-8.82%
|
O:
0.15%
H:
0.0%
C:
0.0%
NBIX
|
News
4
|
$138.91
-0.84%
-0.85%
880K
|
Health Technology
|
48.78%
|
O:
0.04%
H:
1.77%
C:
0.65%
AZN
|
News
|
$71.175
0.46%
0.46%
6.1M
|
Health Technology
|
12.07%
|
O:
0.51%
H:
0.0%
C:
0.0%
ALKS
|
$24.66
1.65%
1.62%
1.7M
|
Health Technology
|
-6.3%
|
O:
-0.19%
H:
2.09%
C:
1.01%
therapeutics
report
Global Huntington's Disease Treatment Market Analysis Report 2023-2030: Novel Approaches, Regional Trends, and Research Endeavors
Published:
2023-09-06
(Crawled : 00:00)
- prnewswire.com
BHC
|
$8.56
0.35%
0.0%
2M
|
Health Technology
|
2.03%
|
O:
-0.96%
H:
1.93%
C:
1.69%
SGMO
|
News
|
$0.4911
-5.72%
-6.07%
1.2M
|
Health Technology
|
-48.0%
|
O:
0.0%
H:
3.0%
C:
-4.77%
NBIX
|
News
4
|
$138.91
-0.84%
-0.85%
880K
|
Health Technology
|
27.16%
|
O:
0.44%
H:
0.23%
C:
-1.97%
disease
report
treatment
research
global
market
Pulmonary arterial hypertension (PAH) drugs market size to grow by USD 2,080.07 million between 2022 and 2027; Growth driven by growing prevalence of PAH - Technavio
Published:
2023-04-18
(Crawled : 07:00)
- prnewswire.com
GLAXF
|
News
|
$19.54
-14.18%
2.6K
|
Health Technology
|
0.0%
|
O:
-6.76%
H:
3.18%
C:
1.34%
AZNCF
|
News
|
$140.3
-4.19%
1.5K
|
Health Technology
|
-4.41%
|
O:
2.33%
H:
0.7%
C:
-0.88%
AVTE
M
|
$21.27
-8.4%
-9.17%
300K
|
Professional, Scientific, and T...
|
27.93%
|
O:
0.0%
H:
2.26%
C:
1.38%
VTRS
|
News
A
|
$11.55
1.67%
1.65%
7.2M
|
Health Technology
|
14.63%
|
O:
0.2%
H:
0.09%
C:
-0.5%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
0.91%
|
O:
0.18%
H:
0.11%
C:
-0.85%
GSK
|
News
|
$40.86
-0.92%
-0.15%
1.7M
|
Health Technology
|
10.3%
|
O:
-0.64%
H:
0.23%
C:
-1.0%
AZN
|
News
|
$71.175
0.46%
0.46%
6.1M
|
Health Technology
|
-3.78%
|
O:
2.35%
H:
0.62%
C:
-0.45%
growing
hypertension
growth
market
Active pharmaceutical ingredients market size to grow by USD 88.74 billion from 2022 to 2027: Increasing number of type II DMFs to drive growth - Technavio
Published:
2023-04-25
(Crawled : 22:00)
- prnewswire.com
GLAXF
|
News
|
$19.54
-14.18%
2.6K
|
Health Technology
|
2.68%
|
O:
-4.57%
H:
0.22%
C:
-1.98%
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
|
-16.59%
|
O:
-1.46%
H:
0.0%
C:
0.0%
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
10.34%
|
O:
0.0%
H:
0.0%
C:
0.0%
VTRS
|
News
A
|
$11.55
1.67%
1.65%
7.2M
|
Health Technology
|
23.75%
|
O:
0.22%
H:
0.65%
C:
-1.09%
TMO
|
News
|
$577.39
0.49%
0.0%
2M
|
Health Technology
|
3.11%
|
O:
-3.72%
H:
2.91%
C:
0.97%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
-4.98%
|
O:
0.62%
H:
0.0%
C:
-2.04%
GSK
|
News
|
$40.86
-0.92%
-0.15%
1.7M
|
Health Technology
|
11.73%
|
O:
-0.03%
H:
0.3%
C:
-2.63%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
2.81%
|
O:
-1.35%
H:
0.36%
C:
-0.54%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-18.13%
|
O:
0.53%
H:
0.0%
C:
0.0%
active
growth
market
Global API and Pharmaceutical Excipients Market Report 2022-2029 Featuring Catalent, Divis Labs, Euroapi Lonza, Pfizer, Samsung Biologics, Teva, Thermo Fisher Scientific, Wuxi Apptec, & Wuxi Biologics
Published:
2023-03-06
(Crawled : 20:00)
- prnewswire.com
CMXHF
|
$176.0
-19.21%
50
|
n/a
|
-10.35%
|
O:
-0.86%
H:
0.33%
C:
0.33%
CSLLY
|
$90.71
3.3%
35K
|
n/a
|
-8.42%
|
O:
-0.02%
H:
0.54%
C:
-1.7%
AZNCF
|
News
|
$140.3
-4.19%
1.5K
|
Health Technology
|
7.76%
|
O:
-2.57%
H:
1.62%
C:
1.62%
TMO
|
News
|
$577.39
0.49%
0.0%
2M
|
Health Technology
|
1.24%
|
O:
0.41%
H:
0.39%
C:
-2.14%
TEVA
|
$13.01
-0.68%
7.5M
|
Health Technology
|
31.28%
|
O:
-1.21%
H:
0.43%
C:
-3.58%
TAK
|
News
|
$13.23
-1.12%
0.0%
920K
|
Health Technology
|
-14.67%
|
O:
0.83%
H:
0.06%
C:
-1.2%
PRGO
|
$31.23
2.43%
0.0%
960K
|
Health Technology
|
-17.51%
|
O:
0.76%
H:
1.91%
C:
1.26%
GSK
|
News
|
$40.86
-0.92%
-0.15%
1.7M
|
Health Technology
|
19.71%
|
O:
0.32%
H:
0.17%
C:
-1.53%
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
131.71%
|
O:
0.01%
H:
0.42%
C:
-2.62%
CTLT
|
$55.95
-0.14%
0.0%
2M
|
Health Technology
|
-21.46%
|
O:
0.11%
H:
0.53%
C:
-5.05%
BMY
|
$48.86
-0.27%
-0.02%
16M
|
Health Technology
|
-28.9%
|
O:
0.41%
H:
0.04%
C:
-1.71%
ALB
|
News
|
$115.27
0.93%
-0.23%
2.2M
|
Process Industries
|
-55.54%
|
O:
-0.95%
H:
1.02%
C:
-2.19%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
9.18%
|
O:
0.19%
H:
0.06%
C:
-1.7%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-1.4%
|
O:
0.65%
H:
0.0%
C:
0.0%
GILD
|
$67.07
0.06%
0.06%
8.3M
|
Health Technology
|
-17.36%
|
O:
0.23%
H:
0.0%
C:
-1.25%
BIIB
|
$201.91
4.52%
4.32%
3.3M
|
Health Technology
|
-28.52%
|
O:
0.28%
H:
0.0%
C:
-2.26%
AZN
|
News
|
$71.175
0.46%
0.46%
6.1M
|
Health Technology
|
9.74%
|
O:
0.9%
H:
0.28%
C:
-1.3%
global
report
market
Central Nervous System (CNS) Stimulant Drugs Market to grow at a CAGR of 5.74 by 2026 | Rise in CNS Disorders to Boost Growth | 17000+ Technavio Reports
Published:
2022-03-14
(Crawled : 16:00)
- prnewswire.com
ALPMF
|
News
|
$9.5
43.47%
1.2K
|
Health Technology
|
-39.49%
|
O:
0.7%
H:
0.0%
C:
0.0%
GLAXF
|
News
|
$19.54
-14.18%
2.6K
|
Health Technology
|
2.09%
|
O:
9.61%
H:
0.0%
C:
-0.57%
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
|
-10.81%
|
O:
-2.53%
H:
0.0%
C:
-0.08%
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
14.35%
|
O:
-3.28%
H:
0.0%
C:
0.0%
ALPMY
|
News
|
$9.49
-1.11%
480K
|
Manufacturing
|
-39.52%
|
O:
2.42%
H:
0.31%
C:
-0.47%
KMPH
|
$5.46
6.04%
0
|
Manufacturing
|
12.62%
|
O:
0.0%
H:
1.34%
C:
-4.4%
VTRS
|
News
A
|
$11.55
1.67%
1.65%
7.2M
|
Health Technology
|
13.37%
|
O:
1.4%
H:
1.08%
C:
-3.44%
TMO
|
News
|
$577.39
0.49%
0.0%
2M
|
Health Technology
|
4.32%
|
O:
-1.31%
H:
0.0%
C:
0.0%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
18.59%
|
O:
0.54%
H:
0.0%
C:
0.0%
GSK
|
News
|
$40.86
-0.92%
-0.15%
1.7M
|
Health Technology
|
0.95%
|
O:
0.42%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-8.76%
|
O:
-3.24%
H:
0.0%
C:
0.0%
JAZZ
|
$108.38
-1.18%
-1.19%
400K
|
Health Technology
|
-29.1%
|
O:
0.1%
H:
1.14%
C:
-0.59%
ENDP
|
News
|
$0.2926
-9.6%
|
Health Technology
|
-87.39%
|
O:
-1.72%
H:
3.51%
C:
-5.26%
BIIB
|
$201.91
4.52%
4.32%
3.3M
|
Health Technology
|
-2.27%
|
O:
0.47%
H:
1.48%
C:
-2.43%
order
drug
system
nervous system
report
growth
Global Glioma Treatment Market Research Report 2023: Breakthrough Oncolytic Virus Therapy Offers New Hope for Glioma Patients - Forecast to 2027 and 2032
Published:
2023-11-27
(Crawled : 23:00)
- prnewswire.com
TMO
|
News
|
$577.39
0.49%
0.0%
2M
|
Health Technology
|
15.37%
|
O:
-0.5%
H:
0.0%
C:
0.0%
KPTI
|
$1.1
0.92%
0.91%
1.2M
|
Health Technology
|
54.06%
|
O:
4.0%
H:
1.93%
C:
-7.72%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
3.51%
|
O:
0.03%
H:
0.85%
C:
0.44%
report
hope
treatment
research
global
virus
therapy
market
Challenges in Transparency and Control Hamper Merchant API Market Growth Despite Pharmaceutical Industry Expansion
Published:
2023-11-10
(Crawled : 00:20)
- prnewswire.com
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
Email alert
Add to watchlist
LZAGY
|
$57.57
0.02%
93K
|
Professional, Scientific, and T...
|
Email alert
Add to watchlist
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
|
Email alert
Add to watchlist
TEVJF
|
News
|
$12.37
-24.22%
380
|
Health Technology
|
Email alert
Add to watchlist
LZAGF
|
$558.779
-19.1%
23
|
Health Technology
|
Email alert
Add to watchlist
TMO
|
News
|
$577.39
0.49%
0.0%
2M
|
Health Technology
|
Email alert
Add to watchlist
control
expansion
growth
market
← Previous
1
2
3
4
5
6
7
8
9
…
31
32
Next →
Gainers vs Losers
62%
38%
Top 10 Gainers
CSSE
4
|
$0.4323
183.85%
64.77%
220M
|
Consumer Services
BOF
|
$1.99
70.09%
41.21%
110M
|
ILAG
|
$0.51
6.03%
40.62%
1.7M
|
LICN
|
$0.941
68.04%
40.49%
15M
|
AMST
|
$3.31
65.5%
39.58%
70M
|
Technology Services
MTC
|
$3.615
61.38%
38.04%
9.3M
|
Technology Services
WIMI
|
$1.15
58.53%
36.92%
19M
|
Technology Services
AIH
|
$0.45
12.5%
30.92%
320K
|
Health Services
MULN
|
News
|
$3.78
38.46%
27.78%
13M
|
Information
RILY
|
$29.86
37.48%
27.26%
12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.